CVE-2015-3953
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.97%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
- CVSS 3.0
- 9.8 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.97% probability · 79th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-259, CWE-798
- Affected
- pifzer/plum a\+ infusion system firmware · pifzer/plum a\+3 infusion system firmware · pifzer/symbiq infusion system firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01Mitigation, Third Party Advisory, US Government Resource
- https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01Mitigation, Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.